Diaclone

Human MICA ELISA Kit

Product Code:
 
850.910.096
Product Group:
 
ELISA Kits
Supplier:
 
Diaclone
Host Type:
 
Human
Regulatory Status:
 
RUO
 

No additional charges, what you see is what you pay! *

CodeSizePrice
850.910.0961 x 96 (pre-coated)£381.00
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: France.
Typical lead time: 14-21 working days.
Contact us for more accurate information.
  • Further Information
  • References
  • Show All

Further Information

Assay Range:
156.25-5000 pg/ml
Cross reaction:
No cross reactivity with IL-7 IL-12p40 IL-2R Trail CD31 IL-13Rα2 IL-5 gp130 TNFα.
Description:
Diaclone ELISA Kits include pre-coated strip plates biotinylated secondary antibody standards controls (where applicable) buffers streptavidin-HRP TMB stop reagents and a detailed procedure.
Detection Target:
MICA
Incubation:
3h45
Reactivity:
Human
Research Area:
Misc
Sample Size:
100 µl
Sample Types:
Supernatant Buffered Solutions. Not suitable for use with serum and plasma.
Sensitivity:
123 pg/ml
Specificity:
Recognizes both natural and recombinant human MICA

References

  1. Arai J. et al. Cancer Immunol Immunother. 2021; 70(1): 203?213. . Leukotriene receptor antagonists enhance HCC treatment efficacy by inhibiting ADAMs and suppressing MICA shedding. https://pubmed.ncbi.nlm.nih.gov/32683508/
  2. Bedel R. et al. Cancer Res.2011;71(5): 1615-1626. Novel Role for STAT3 in Transcriptional Regulation of NK Immune Cell Targeting Receptor MICA on Cancer Cells. https://www.ncbi.nlm.nih.gov/pubmed/21257710
  3. Goto K. et al. Sci Rep.2016; 6: 38407. Novel chemoimmunotherapeutic strategy for hepatocellular carcinoma based on a genome-wide association study. https://www.ncbi.nlm.nih.gov/pubmed/27910927
  4. Goto K. et al.Oncotarget. 2018 Apr 10;9(27):18821-18831.. Novel therapeutic features of disulfiram against hepatocellular carcinoma cells with inhibitory effects on a disintegrin and metalloproteinase 10.. https://www.ncbi.nlm.nih.gov/pubmed/29721164